Firefly Neuroscience (AIFF) Shares Outstanding (Weighted Average) (2016 - 2025)

Firefly Neuroscience has reported Shares Outstanding (Weighted Average) over the past 15 years, most recently at $12.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $12.4 million for Q4 2025, up 90.07% from a year ago — trailing twelve months through Dec 2025 was $12.4 million (up 90.07% YoY), and the annual figure for FY2025 was $12.4 million, up 90.07%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $12.4 million at Firefly Neuroscience, up from $1.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for AIFF hit a ceiling of $17.3 million in Q1 2022 and a floor of $33467.0 in Q4 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $5.9 million (2024), compared with a mean of $7.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 99.73% in 2022 and later surged 9561.07% in 2023.
  • Firefly Neuroscience's Shares Outstanding (Weighted Average) stood at $12.6 million in 2021, then tumbled by 99.73% to $33467.0 in 2022, then surged by 9561.07% to $3.2 million in 2023, then soared by 102.48% to $6.5 million in 2024, then skyrocketed by 90.07% to $12.4 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $12.4 million (Q4 2025), $1.7 million (Q3 2025), and $11.3 million (Q2 2025) per Business Quant data.